AI Verdict
GOOGL has stronger fundamentals based on our AI analysis.
MED vs GOOGL Fundamental Comparison
| Metric | MED | GOOGL |
|---|---|---|
| Revenue | $385.8M | $402.8B |
| Net Income | $-18.7M | $132.2B |
| Net Margin | -4.8% | 32.8% |
| ROE | -9.4% | 31.8% |
| ROA | -7.5% | 22.2% |
| Current Ratio | 4.69x | 2.01x |
| Debt/Equity | 0.00x | 0.12x |
| EPS | $-1.70 | $10.81 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MED vs GOOGL: Frequently Asked Questions
Is MED or GOOGL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GOOGL has stronger fundamentals. MED is rated SELL (85% confidence) while GOOGL is rated BUY (91% confidence). This is not investment advice.
How does MED compare to GOOGL fundamentally?
MEDIFAST INC has ROE of -9.4% vs Alphabet Inc.'s 31.8%. Net margins are -4.8% vs 32.8% respectively.
Which stock pays higher dividends, MED or GOOGL?
MED has a dividend yield of N/A or no dividend while GOOGL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MED or GOOGL for long term?
For long-term investing, consider that MED has SELL rating with 85% confidence, while GOOGL has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MED vs GOOGL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MED vs GOOGL, the AI consensus favors GOOGL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.